Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Pieris Pharmaceuticals Inc. (PIRS)

3.95   0.05 (1.28%) 11-11 16:00
Open: 4.05 Pre. Close: 3.9
High: 4.18 Low: 3.76
Volume: 1,116,484 Market Cap: 195M
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in discovering and developing Anticalin class of biotherapeutics for patients with diseases in which there is high unmet medical needs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.184 - 4.2 4.2 - 4.218
Low: 3.72 - 3.736 3.736 - 3.754
Close: 3.919 - 3.946 3.946 - 3.976

Technical analysis

as of: 2019-11-11 4:35:00 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 4.96     One year: 5.80
Support: Support1: 3.40    Support2: 2.87
Resistance: Resistance1: 4.25    Resistance2: 4.96
Pivot: 3.49
Moving Average: MA(5): 3.92     MA(20): 3.42
MA(100): 4.37     MA(250): 3.70
MACD: MACD(12,26): 0.05     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 70.05     %D(3): 71.44
RSI: RSI(14): 58.42
52-week: High: 6.04  Low: 2.39  Change(%): 20.1
Average Vol(K): 3-Month: 70910  10-Days: 72806

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PIRS has closed below upper band by 16.8%. Bollinger Bands are 9.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 30 Jul 2019 01:32:57 +0000
6 Top Gainers In Healthcare Sector (NBY, PIRS, VRCA...)

Wed, 12 Jun 2019 17:08:19 +0000
These 4 Charts Looking Higher

Mon, 13 May 2019 21:18:24 +0000
5 Top Gainers In Pharma Sector (TWST, NOVN, CMRX…)

Fri, 16 Mar 2018 12:37:00 +0000
Proteostasis Therapeutics (PTI) Looks Good: Stock Adds 8% in Session

Sun, 18 Feb 2018 11:00:00 +0000
3 Top Biotech Stocks to Buy in February

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 49.39
Shares Float (M) 41.44
% Held by Insiders 0.23
% Held by Institutions 72.84
Shares Short (K) 1780
Shares Short P. Month (K)

Stock Financials

EPS -0.767
Book Value (p.s.) 0.400
PEG Ratio
Profit Margin -147.20
Operating Margin -159.81
Return on Assets (ttm) -18.5
Return on Equity (ttm) -106.8
Qtrly Rev. Growth -54.4
Gross Profit (p.s.) 0.589
Sales Per Share
EBITDA (p.s.) -0.868
Qtrly Earnings Growth
Operating Cash Flow (M) -49.26
Levered Free Cash Flow (M) -40.78

Stock Valuations

P/E -5.15
P/E Growth Ratio 0.01
P/BV 9.88
P/S 7.59
P/CF -3.96

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-12-08
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.